Literature DB >> 18330608

Delayed spinal infection after laminectomy in a patient with rheumatoid arthritis interruptedly exposed to anti-tumor necrosis factor alpha agents.

Shunsuke Mori1, Yusuke Tomita, Tomohiro Horikawa, Isamu Cho, Mineharu Sugimoto.   

Abstract

We report a case of spondylodiscitis caused by Staphylococcus aureus 8 months after laminectomy of the lumbar spine, occurring in a rheumatoid arthritis (RA) patient interruptedly treated with anti-tumor necrosis alpha (TNFalpha) agents. The patient had suffered from seropositive RA for 2 years. An intravenous infusion (200 mg) of infliximab, a chimeric antibody against human TNFalpha, was introduced; however, due to Pneumocystis jiroveci pneumonia, this therapy was withdrawn. Four months later, the patient underwent an L3-L4 and L4-L5 laminectomy for spinal stenosis. Two months after surgery, we started treatment with 25 mg of etanercept, a soluble humanized TNF receptor dimer, subcutaneously twice a week. At that time, wound healing was satisfactory and no evidence of infection was obtained. Eight months after surgery, septic spondylodiscitis of the lumbar spine occurred. To the best of our knowledge, this is the first case in the literature to show a delayed type of postoperative infection as a complication of non-instrumented orthopedic surgical procedures. Despite interruption of anti-TNFalpha therapy before surgery, patients may remain at risk of developing postoperative infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18330608     DOI: 10.1007/s10067-008-0869-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001).

Authors:  J Ledingham; C Deighton
Journal:  Rheumatology (Oxford)       Date:  2005-01-05       Impact factor: 7.580

3.  Postoperative spinal wound infection: a review of 2,391 consecutive index procedures.

Authors:  M A Weinstein; J P McCabe; F P Cammisa
Journal:  J Spinal Disord       Date:  2000-10

Review 4.  Infections associated with tumor necrosis factor-alpha antagonists.

Authors:  David J Rychly; Joseph T DiPiro
Journal:  Pharmacotherapy       Date:  2005-09       Impact factor: 4.705

Review 5.  Postoperative infections of the thoracic and lumbar spine: a review of 18 cases.

Authors:  Pavlos Katonis; Michael Tzermiadianos; Panayiotis Papagelopoulos; Alexander Hadjipavlou
Journal:  Clin Orthop Relat Res       Date:  2007-01       Impact factor: 4.176

6.  Experience with etanercept in an academic medical center: are infection rates increased?

Authors:  Kristine Phillips; M Elaine Husni; Elizabeth W Karlson; Jonathan S Coblyn
Journal:  Arthritis Rheum       Date:  2002-02

7.  Postoperative wound infections complicating adult spine surgery.

Authors:  J L Stambough; D Beringer
Journal:  J Spinal Disord       Date:  1992-09

8.  Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers.

Authors:  A Ruyssen-Witrand; L Gossec; C Salliot; M Luc; M Duclos; S Guignard; M Dougados
Journal:  Clin Exp Rheumatol       Date:  2007 May-Jun       Impact factor: 4.473

Review 9.  Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis.

Authors:  Ryuji Koike; Tsutomu Takeuchi; Katsumi Eguchi; Nobuyuki Miyasaka
Journal:  Mod Rheumatol       Date:  2007-12-20       Impact factor: 3.023

10.  Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases.

Authors:  Kenichiro Tamaki; Yoshinori Kogata; Daisuke Sugiyama; Takashi Nakazawa; Saori Hatachi; Gohichi Kageyama; Kunihiro Nishimura; Akio Morinobu; Shunichi Kumagai
Journal:  J Rheumatol       Date:  2007-11-15       Impact factor: 4.666

View more
  3 in total

1.  Late-onset deep surgical-site infection after posterior lumbar interbody fusion in a patient treated with tocilizumab; unusual changes in inflammatory markers.

Authors:  Takahiro Makino; Takashi Kaito; Hideki Tsuboi; Hiroyasu Fujiwara; Kazuo Yonenobu
Journal:  Eur Spine J       Date:  2014-04-24       Impact factor: 3.134

2.  Rheumatoid Arthritis in Spine Surgery: A Systematic Review and Meta-Analysis.

Authors:  Benjamin D Streufert; Chiduziem Onyedimma; Yagiz U Yolcu; Abdul Karim Ghaith; Benjamin D Elder; Ahmad Nassr; Bradford Currier; Arjun S Sebastian; Mohamad Bydon
Journal:  Global Spine J       Date:  2022-03-18

3.  Increased dosage of infliximab is a potential cause of Pneumocystis carinii pneumonia.

Authors:  Takuya Iwama; Aki Sakatani; Mikihiro Fujiya; Kazuyuki Tanaka; Shugo Fujibayashi; Yoshiki Nomura; Nobuhiro Ueno; Shin Kashima; Takuma Gotoh; Junpei Sasajima; Kentaro Moriichi; Katsuya Ikuta
Journal:  Gut Pathog       Date:  2016-02-02       Impact factor: 4.181

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.